AstraZeneca
new frontiers for in her low breast cancer and her lung cancer | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
April 2022
Slide
15 of 40
Related slides by other companies
Genprex
Investor Presentation
October 2022
lead program non small cell lung cancer | Genprex
Dare Bioscience
Investor Presentation
February 2023
dare | Dare Bioscience
Genelux
Investor Presentation
December 2023
program builds on completed trials to exploit competitive advantages estimated billion dollar plus annual commercial opportunity us | Genelux
Genelux
Investor Presentation
February 2024
program builds on completed trials to exploit competitive advantages estimated billion dollar plus annual commercial opportunity us | Genelux
Other recent decks by AstraZeneca
See all presentations (27 decks)
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io